An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

To support the registration of sitagliptin 100mg in china.

Phase 1

Merck Sharp & Dohme Corp.

Sitagliptin Phosphate